Water-filtered Infrared-A Radiation in Patients With Hand Osteoarthritis

Charité University Medicine Berlin

Status: Enrolling

Conditions: Hand Osteoarthritis

Treatments: Device: water-filtered Infrared-A radiation

Study type: Interventional

Funder types: Other

Identifiers

NCT06329219

wIRA

Details and patient eligibility

About

The aim of this clinical trial is to evaluate the effects of water-filtered Infrared-A radiation on patients suffering from hand osteoarthritis. The main questions it aims to answer are:

• Does water-filtered Infrared-A radiation reduce pain and improve the function of finger joints over time?
• Are patients satisfied with the treatment results when compared to those who were on a wait-list?

Enrollment: 70 estimated patients

Sex: All

Ages: 18 to 85 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Diagnosis of finger polyarthritis (confirmed by a specialist, radiological findings available)
• Local pain for more than 50% of the day in the past 3 months.
• Subjective pain intensity of local pain in the last 24 hours on a VAS scale of 0 to 10 being >4.
• No planned local treatment in the next 6 months.
• No planned intra-articular injections within the next 6 months.
• The patient must be able to understand the study explanations and appropriately follow the instructions of the investigating physician.

Exclusion criteria

• Chronic inflammatory joint diseases.
• Poor general health.
• Febrile diseases.
• Fibromyalgia syndrome.
• Psychotic disorders.
• Severe comorbidities.
• Acute unclear skin diseases.
• Heat urticaria.
• Painful diseases/diagnoses of the shoulder and/or arm.
• Lymphatic vessel diseases (lymphedema, lymphangitis).
• Porphyria.
• Pain-associated diseases/diagnoses of the shoulder and/or arm.
• Intra-articular injections or arthroscopies within the last 3 months.
• Previous or planned surgical procedure on the affected joints in the last 8 weeks or in the upcoming 6 months.
• Intake or application of photosensitizing drugs or extracts (e.g., porphyrins, tetracyclines, sulfonamides, psoralenes, St. John's wort).
• Systemic medication with glucocorticoids or immunosuppressants.
• Pain medication with opioid analgesics.
• Known pregnancy.
• Concurrent participation in another clinical trial.

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: None (Open label)

---

70 participants in 2 patient groups

Radiation

Experimental group

Description:

Participants in the intervention group each receive a hyperthermia device for water-filtered Infrared-A radiation.

Treatment:

Device: water-filtered Infrared-A radiation

Waiting list

No Intervention group

Description:

Participants in the control group initially receive no therapeutic intervention, but can receive it after the study's last visit for 3 months.